These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7585535)

  • 1. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition.
    Stanwell C; Burke TR; Yuspa SH
    Cancer Res; 1995 Nov; 55(21):4950-6. PubMed ID: 7585535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
    Dlugosz AA; Yuspa SH
    Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
    Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM
    Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells.
    King I; Sartorelli AC
    Cancer Res; 1989 Oct; 49(20):5677-81. PubMed ID: 2790786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope.
    Brown DR; Kitchin D; Qadadri B; Neptune N; Batteiger T; Ermel A
    Virology; 2006 Feb; 345(1):290-8. PubMed ID: 16257432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Levitzki R; Chaouat M; Shlomai Z; Klein BY; Kleinberger-Doron N; Gazit A; Tsvieli R; Levitzki A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1442-57. PubMed ID: 10454524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of interleukin-6 (IL-6) expression in squamous carcinoma cells and normal human keratinocytes treated with recombinant anti-neoplastic protein (ACP).
    McKenzie RC; Venner TJ; Sauder DN; Farkas-Himsley H
    Anticancer Res; 1994; 14(3A):1165-8. PubMed ID: 8074468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
    Yoshinaka Y; Katoh I; Kyushiki H; Sakamoto Y
    Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Shlomai Z; Kleinberger-Doron N; Gazit A; Plowman G; Levitzki R; Tsvieli R; Levitzki A
    Cancer Res; 1997 Sep; 57(17):3741-50. PubMed ID: 9288782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
    Piazza GA; Ritter JL; Baracka CA
    Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.